Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Nuvation Bio Inc. completes acquisition of AnHeart Therapeutics Ltd. to enhance its oncology pipeline
Acquiring Company
Nuvation Bio
Acquired Company
AnHeart Therapeutics
New YorkNew YorkBiotechnologyHealthcareHealth CareTherapeuticsBiopharmaManufacturingBiotechnologyHealth CareScience And EngineeringTherapeuticsPharmaceuticalBiopharmaDescription
Nuvation Bio Inc., a late-stage global biopharmaceutical company, has successfully completed the acquisition of AnHeart Therapeutics Ltd. This acquisition transforms Nuvation Bio into a well-capitalized, late-stage, global oncology company, expanding its pipeline and positioning it to become a commercial organization.
Fundz sees it the moment Nuvation Bio makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired AnHeart Therapeutics?
AnHeart Therapeutics was acquired by Nuvation Bio, based in New York. The deal was reported on April 10, 2024. Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio is publicly traded (NUVB) and operates in Biotechnology.
When did Nuvation Bio acquire AnHeart Therapeutics?
Nuvation Bio's acquisition of AnHeart Therapeutics was reported on April 10, 2024. Nuvation Bio Inc., a late-stage global biopharmaceutical company, has successfully completed the acquisition of AnHeart Therapeutics Ltd. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does AnHeart Therapeutics do?
AnHeart Therapeutics Ltd. is a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer. It is privately held, operating in Manufacturing, and is based in New York.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.